Kate Bingham serves as Executive at BICYCLE THERAPEUTICS plc, where they oversee executive responsibilities. Since joining the company, Kate Bingham has executed 14 insider transactions totaling $8.5M, demonstrating a bullish approach to their equity position. Their most recent transaction on Jul 14, 2021 involved selling 917 shares valued at $31.2K.
Kate Bingham currently holds 38,708 shares of BICYCLE THERAPEUTICS plc (BCYC), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Kate Bingham has been a net buyer of BCYC stock. They have purchased $5.4M and sold $3.1M worth of shares.
Kate Bingham's most recent insider trade was on Jul 14, 2021, when they sold 917 shares at $34.01 per share.
Get notified when new Form 4 filings are submitted
| $34.01 |
| Discretionary |
| Jul 14, 2021 | BCYC | $31.2K | Sale | 917 | $34.01 | Discretionary |
| Jul 14, 2021 | BCYC | $1.5M | Sale | 43,378 | $34.01 | Discretionary |
| Jul 13, 2021 | BCYC | $402 | Sale | 12 | $33.50 | Discretionary |
| Jul 13, 2021 | BCYC | $19.7K | Sale | 588 | $33.50 | Discretionary |
| Jul 13, 2021 | BCYC | $19.7K | Sale | 588 | $33.50 | Discretionary |
| Jul 13, 2021 | BCYC | $402 | Sale | 12 | $33.50 | Discretionary |
| May 28, 2019 | BCYC | $0 | Conversion | 13,169 | $N/A | Discretionary |
| May 28, 2019 | BCYC | $0 | Conversion | 18,485 | $N/A | Discretionary |
| May 28, 2019 | BCYC | $111.8K | Purchase | 7,983 | $14.00 | Discretionary |
| May 28, 2019 | BCYC | $5.3M | Purchase | 377,732 | $14.00 | Discretionary |
| May 28, 2019 | BCYC | $0 | Conversion | 623,196 | $N/A | Discretionary |
| May 28, 2019 | BCYC | $0 | Conversion | 874,709 | $N/A | Discretionary |